Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PTC Therapeutics Inc.

www.ptcbio.com

Latest From PTC Therapeutics Inc.

Real-World Data Boost Santhera's Latest DMD Filing, And The Markets Agree

Despite being knocked back twice, Santhera CEO Thomas Meier is still confident Raxone has a place as a Duchenne muscular dystrophy therapy, and believes new long-term data will strengthen its third application to the EU in the coming months.

Rare Diseases Clinical Trials

Roche $4.8bn Buy Sparks Hemophilia Gene Therapy Race

The Swiss major's proposed acquisition of Spark Therapeutics gives it a leading seat at the table in the emerging field of gene therapy.

M & A Blood & Coagulation Disorders

J.P. Morgan Roundtable: The Regulatory Role In Accelerating Complex Therapies

Companies working on cell and gene therapies and novel approaches to neurological diseases participated in a roundtable discussion during the J.P. Morgan Healthcare Conference about how regulators are supporting novel modalities, which in turn improves investor and partner sentiment.

Regenerative Medicine Research and Development Strategies

J.P. Morgan Roundtable: The Regulatory Role In Accelerating Complex Therapies

Part 3: Scrip spoke with companies working on cell and gene therapies and novel approaches to neurological diseases during the J.P. Morgan Healthcare Conference about how regulators are supporting novel modalities, which in turn improves investor and partner sentiment.

Business Strategies Research and Development Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • PTC Therapeutics Inc.
  • Senior Management
  • Stuart W Peltz, PhD, CEO
    Mark J Pykett, PhD, CSO
    Megan Sniecinski , SVP, Bus. Operations & Program Mgmt.
    Marcio Souza, COO
    Christine Utter, Principal Financial Officer & Treasurer
  • Contact Info
  • PTC Therapeutics Inc.
    Phone: (908) 222-7000
    100 Corporate Ct.
    South Plainfield, NJ 07080-2449
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register